Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other Non-Current Assets (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Other Non-Current Assets for 8 consecutive years, with $414.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 11.15% to $414.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $414.4 million, a 11.15% increase, with the full-year FY2025 number at $414.4 million, up 11.15% from a year prior.
  • Other Non-Current Assets was $414.4 million for Q4 2025 at Select Medical Holdings, up from $388.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $414.4 million in Q4 2025 to a low of $326.1 million in Q1 2021.
  • A 5-year average of $368.9 million and a median of $368.9 million in 2023 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: grew 23.11% in 2022, then dropped 10.42% in 2023.
  • Select Medical Holdings' Other Non-Current Assets stood at $338.7 million in 2021, then increased by 0.91% to $341.7 million in 2022, then rose by 7.78% to $368.3 million in 2023, then increased by 1.22% to $372.8 million in 2024, then grew by 11.15% to $414.4 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Other Non-Current Assets are $414.4 million (Q4 2025), $388.4 million (Q3 2025), and $367.2 million (Q2 2025).